Surgical Site Infection Control Market Report 2026

Surgical Site Infection Control Market Report 2026
Global Outlook – By Product (Surgical Scrubs, Hair Clippers, Surgical Drapes, Surgical Irrigation, Skin Preparation Solution, Medical Nonwovens, Surgical Gloves, Manual Reprocessor Solution, Disinfectants, Other Products), By Type Of Infection (Superficial Incisional Surgical Site Infection (SSI), Deep Incisional Surgical Site Infection (SSI), Organ Or Space Surgical Site Infection (SSI)), By Surgery Type (Cesarean Section, Gastric Bypass, Cataract Surgery, Dental Restoration, Other Surgery Types), By End-user (Hospitals, Ambulatory Surgical Centers, Other End Users) - Market Size, Trends, And Global Forecast 2026-2035
Surgical Site Infection Control Market Overview
• Surgical Site Infection Control market size has reached to $4.96 billion in 2025 • Expected to grow to $6.16 billion in 2030 at a compound annual growth rate (CAGR) of 4.3% • Growth Driver: Surgical Site Infection Control Strategies In Response To Increasing Surgical Procedures • Market Trend: Advancements In Surgical Infection Prevention And Patient Safety • North America was the largest region in 2025.What Is Covered Under Surgical Site Infection Control Market?
Surgical site infection (SSI) control refers to a set of practices aimed at preventing infections that occur at or near a surgical incision within 30 days of the procedure (or up to 90 days for certain surgeries). These practices include maintaining sterile conditions, proper hand hygiene, antibiotic prophylaxis, and post-operative wound care. Effective SSI control is essential to reducing patient morbidity, mortality, and healthcare costs. The main product types for surgical site infection control are surgical scrubs, hair clippers, surgical drapes, surgical irrigation, skin preparation solutions, medical nonwovens, surgical gloves, manual reprocessor solutions, disinfectants, and others. Surgical scrubs are specialized garments worn by surgical personnel to maintain cleanliness and reduce the spread of microorganisms during procedures. The various infections are superficial incisional surgical site infection (SSI), deep incisional surgical site infection (SSI), and organ or space surgical site infection (SSI). It is useful in different surgeries, including cesarean sections, gastric bypass, cataract surgery, dental restoration, and others, and is used by various end-users, such as hospitals, ambulatory surgical centers, and others.
What Is The Surgical Site Infection Control Market Size and Share 2026?
The surgical site infection control market size has grown steadily in recent years. It will grow from $4.96 billion in 2025 to $5.2 billion in 2026 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to increasing surgical procedure volumes, rising awareness of healthcare-associated infections, expansion of hospital infrastructure, wider availability of antiseptic and disinfectant products, strengthening of clinical hygiene standards.What Is The Surgical Site Infection Control Market Growth Forecast?
The surgical site infection control market size is expected to see steady growth in the next few years. It will grow to $6.16 billion in 2030 at a compound annual growth rate (CAGR) of 4.3%. The growth in the forecast period can be attributed to increasing investments in infection control technologies, rising regulatory enforcement of infection prevention guidelines, expansion of digital hospital monitoring systems, growing focus on patient safety outcomes, increasing adoption of antimicrobial surgical solutions. Major trends in the forecast period include increasing adoption of comprehensive infection prevention protocols, rising use of advanced sterilization products, growing integration of digital ssi monitoring systems, expansion of disposable surgical consumables, enhanced focus on post-operative infection reduction.Global Surgical Site Infection Control Market Segmentation
1) By Product: Surgical Scrubs, Hair Clippers, Surgical Drapes, Surgical Irrigation, Skin Preparation Solution, Medical Nonwovens, Surgical Gloves, Manual Reprocessor Solution, Disinfectants, Other Products 2) By Type Of Infection: Superficial Incisional Surgical Site Infection (SSI), Deep Incisional Surgical Site Infection (SSI), Organ Or Space Surgical Site Infection (SSI) 3) By Surgery Type: Cesarean Section, Gastric Bypass, Cataract Surgery, Dental Restoration, Other Surgery Types 4) By End-user: Hospitals, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Surgical Scrubs: Antimicrobial Surgical Scrubs, Non-Antimicrobial Surgical Scrubs 2) By Hair Clippers: Corded Hair Clippers, Cordless Hair Clippers 3) By Surgical Drapes: Sterile Surgical Drapes, Disposable Surgical Drapes, Reusable Surgical Drapes 4) By Surgical Irrigation: Sterile Irrigation Fluids, Antiseptic Irrigation Solutions, Non-Antiseptic Irrigation Solutions 5) By Skin Preparation Solution: Alcohol-Based Skin Preparations, Chlorhexidine-Based Skin Preparations, Povidone-Iodine-Based Skin Preparations 6) By Medical Nonwovens: Surgical Gowns, Surgical Masks, Sterile Sponges And Pads 7) By Surgical Gloves: Latex Surgical Gloves, Nitrile Surgical Gloves, Vinyl Surgical Gloves, Powdered Surgical Gloves, Powder-Free Surgical Gloves 8) By Manual Reprocessor Solution: Enzyme-Based Reprocessing Solutions, Chemical-Based Reprocessing Solutions 9) By Disinfectants: Alcohol-Based Disinfectants, Chlorine-Based Disinfectants, Hydrogen Peroxide-Based Disinfectants 10) By Other Products: Wound Care Products, Sterilization Equipment, Antiseptic TowelettesWhat Is The Driver Of The Surgical Site Infection Control Market?
The rising number of surgical procedures is expected to propel the growth of the surgical site infection control market going forward. Surgical procedures are growing due to advancements in technology, expanding elderly populations, and increasing chronic disease burdens. Surgical site infection controls, including sterilization, antibiotic prophylaxis, and aseptic techniques, are essential in surgical procedures to prevent infections, reduce complications, and improve patient outcomes. For instance, in September 2023, according to the National Library of Medicine, a US-based federal government, as of 2023, 7,733 robotic surgical systems were installed worldwide, and more than 10 million robotic surgeries have been carried out. Therefore, the rising number of surgical procedures is driving the growth of the surgical site infection control industry.Key Players In The Global Surgical Site Infection Control Market
Major companies operating in the surgical site infection control market are Johnson and Johnson, Thermo Fisher Scientific Inc., 3M Company, Kimberly-Clark Corporation, Becton Dickinson and Company, Owens & Minor Inc., B. Braun Melsungen AG, Smith & Nephew plc, Hartmann Group, ConvaTec Inc., Ansell Limited, Mölnlycke Health Care, Halyard Health Inc., DeRoyal Industries Inc., Excelsior Medical LLC, Precept Medical Products Inc., Cantel Medical Corp, Medline Industries LP, Cardinal Health Inc., Terumo Corporation, Stryker Corporation, Philips HealthcareGlobal Surgical Site Infection Control Market Trends and Insights
Major companies operating in the surgical site infection control market are focusing on developing innovative solutions to surgical site infection control to reduce infection rates, enhance patient safety, and improve postoperative outcomes in healthcare settings. Surgical site infection control refers to the strategies, products, and practices aimed at preventing infections at the site of a surgical incision, thereby reducing postoperative complications and improving patient outcomes. For instance, in November 2025, BD (Becton, Dickinson and Company), a US-based medical technology company, launched BD Surgiphor in Europe. The device is designed to improve surgical safety by minimizing contamination risks during procedures, supporting sterile practices, and reducing the incidence of surgical site infections. With this launch, BD aims to strengthen its surgical safety portfolio, drive adoption of advanced infection control solutions, and enhance patient outcomes in operating rooms across Europe.What Are Latest Mergers And Acquisitions In The Surgical Site Infection Control Market?
In February 2023, Ansell Limited, an Australia-based manufacturing company, acquired a 50% shareholding in Careplus (M) Sdn Bhd for US$9 million. The acquisition aligns with Ansell's objective to secure greater control over its supply chain and production. Careplus (M) Sdn Bhd is a Malaysia-based manufacturer of surgical, latex, and nitrile powder-free gloves.Regional Outlook
North America was the largest region in the surgical site infection control market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Surgical Site Infection Control Market?
The surgical site infection control market consists of sales of sterile surgical gloves and instruments, antiseptic skin preparation solutions, and post-operative dressings. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Surgical Site Infection Control Market Report 2026?
The surgical site infection control market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the surgical site infection control industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Surgical Site Infection Control Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $5.2 billion |
| Revenue Forecast In 2035 | $6.16 billion |
| Growth Rate | CAGR of 4.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Type Of Infection, Surgery Type, End-user |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Johnson and Johnson, Thermo Fisher Scientific Inc., 3M Company, Kimberly-Clark Corporation, Becton Dickinson and Company, Owens & Minor Inc., B. Braun Melsungen AG, Smith & Nephew plc, Hartmann Group, ConvaTec Inc., Ansell Limited, Mölnlycke Health Care, Halyard Health Inc., DeRoyal Industries Inc., Excelsior Medical LLC, Precept Medical Products Inc., Cantel Medical Corp, Medline Industries LP, Cardinal Health Inc., Terumo Corporation, Stryker Corporation, Philips Healthcare |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Surgical Site Infection Control market was valued at $4.96 billion in 2025, increased to $5.2 billion in 2026, and is projected to reach $6.16 billion by 2030.
request a sample hereThe global Surgical Site Infection Control market is expected to grow at a CAGR of 4.3% from 2026 to 2035 to reach $6.16 billion by 2035.
request a sample hereSome Key Players in the Surgical Site Infection Control market Include, Johnson and Johnson, Thermo Fisher Scientific Inc., 3M Company, Kimberly-Clark Corporation, Becton Dickinson and Company, Owens & Minor Inc., B. Braun Melsungen AG, Smith & Nephew plc, Hartmann Group, ConvaTec Inc., Ansell Limited, Mölnlycke Health Care, Halyard Health Inc., DeRoyal Industries Inc., Excelsior Medical LLC, Precept Medical Products Inc., Cantel Medical Corp, Medline Industries LP, Cardinal Health Inc., Terumo Corporation, Stryker Corporation, Philips Healthcare .
request a sample hereMajor trend in this market includes: Advancements In Surgical Infection Prevention And Patient Safety . For further insights on this market.
request a sample hereNorth America was the largest region in the surgical site infection control market in 2025. The regions covered in the surgical site infection control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
request a sample here